Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 963 of 1,261
  1. US 7951557

    Human lysosomal proteins from plant cell culture

    Protalix Ltd. · Granted May 31, 2011 · Expires May 26, 2031

    granted
  2. US 7951786

    Method of treating inflammatory arthropathies with suppressors of CpG oligonucleotides

    The United States of America, as represented by the Department of Health and Human Services · Granted May 31, 2011 · Expires May 26, 2031

    granted
  3. US 7951787

    Phosphoramidate compounds and methods of use

    Cardiff Protides Limited · Granted May 31, 2011 · Expires May 26, 2031

    granted
  4. US 7951770

    Peptides, peptidomimetics and small molecule inhibitors of the Epstein-Barr virus mediated fusion and entry process

    Northwestern University · Granted May 31, 2011 · Expires May 26, 2031

    granted
  5. US 7951851

    Curable composition for dental purposes

    Kuraray Medical Inc. · Granted May 31, 2011 · Expires May 26, 2031

    granted
  6. US 7951362

    Compositions and methods of use of targeting peptides against placenta and adipose tissues

    The Board of Regents of the University of Texas System · Granted May 31, 2011 · Expires May 26, 2031

    granted
  7. US 7951383

    Attenuated parainfluenza virus (PIV) vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted May 31, 2011 · Expires May 26, 2031

    granted
  8. US 7951390

    Slow-release microcapsule composition for safe delivery of agriculturally active material

    United Phosphorus Limited · Granted May 31, 2011 · Expires May 26, 2031

    granted
  9. US 7951817

    Pyridomorphinans, pyridazinomorphinans and use thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted May 31, 2011 · Expires May 26, 2031

    granted
  10. US 7951820

    Triazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 31, 2011 · Expires May 26, 2031

    granted
  11. US 7951909

    Immunogenic peptide composition comprising a promiscuous helper T cell epitope and an N-terminal fragment of Aβ1-42 peptide

    United Biomedical, Inc. · Granted May 31, 2011 · Expires May 26, 2031

    granted
  12. US 7951925

    Methods and compositions for gene inactivation

    Sangamo Biosciences, Inc. · Granted May 31, 2011 · Expires May 26, 2031

    granted
  13. US 7951845

    Composition and method of treating hearing loss

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 31, 2011 · Expires May 26, 2031

    granted
  14. US 7947710

    Disubstituted alkyl-8-azabicyclo[3.2.1]octane compounds as mu opioid receptor antagonists

    Theravance, Inc. · Granted May 24, 2011 · Expires May 19, 2031

    granted
  15. US 7947822

    HIV vaccines based on Env of multiple clades of HIV

    The United States of America, as represented by the Department of Health and Human Services · Granted May 24, 2011 · Expires May 19, 2031

    granted
  16. US 7947289

    Multimeric protein toxins to target cells having multiple identifying characteristics

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 24, 2011 · Expires May 19, 2031

    granted
  17. US 7947659

    iRNA agents targeting VEGF

    Alnylam Pharmaceuticals, Inc. · Granted May 24, 2011 · Expires May 19, 2031

    granted
  18. US 7947651

    Secreted frizzled related protein, sFRP, fragments and methods of use thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted May 24, 2011 · Expires May 19, 2031

    granted
  19. US 7947261

    Conjugates formed from polymer derivatives having particular atom arrangements

    Nektar Therapeutics · Granted May 24, 2011 · Expires May 19, 2031

    granted
  20. US 7947649

    Liquid buffered GDF-5 formulations

    Advanced Technologies and Regenerative Medicine, LLC · Granted May 24, 2011 · Expires May 19, 2031

    granted
  21. US 7947681

    Methods of administering tetrahydrobiopterin, associated compositions, and methods of measuring

    BIOMARIN PHARMACEUTICAL INC. · Granted May 24, 2011 · Expires May 19, 2031

    granted
  22. US 7947698

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted May 24, 2011 · Expires May 19, 2031

    granted
  23. US 7947720

    3,4-di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands

    Pharmacopeia Drug Discovery, Inc. · Granted May 24, 2011 · Expires May 19, 2031

    granted
  24. US 7947726

    Non-steroidal ligands for the glucocorticoid receptor, and compositions thereof

    The Regents of the University of California · Granted May 24, 2011 · Expires May 19, 2031

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.